A Real World Study on the Efficacy and Safety of Lacosamide as Add-on Therapy for Focal-onset Epilepsy

UnknownOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

January 31, 2021

Primary Completion Date

November 28, 2021

Study Completion Date

February 28, 2022

Conditions
EpilepsyFocal-Onset Seizure
Interventions
DRUG

lacosamide

lacosamide as first add on therapy

Trial Locations (19)

610000

West China Hospital of Sichuan University, Chengdu

Unknown

Beijing Children's Hospital affiliated to Capital Medical University, Beijing

The First Affiliated Hospital of Jinan University, Guangzhou

The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou

Shenzhen Children's Hospital, Shenzhen

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

Wuhan Union Hospital, Wuhan

Xiangya Hospital of Central South University, Changsha

Nanjing Brain Hospital, Nanjing

The Children's Hospital Affiliated to Suzhou University, Suzhou

Wuhan Children's Hospital, Wuhan

The First Hospital of Jilin University, Changchun

The First Affiliated Hospital of China Medical University, Shenyang

Shandong Provincial Hospital, Jinan

Huashan hospital affiliated to Fudan University, Shanghai

The Children's Hospital of Fudan University, Shanghai

The Second Affiliated Hospital of Xi'an Jiaotong University College of Medicine, Xi’an

West China Second Hospital of Sichuan University, Chengdu

Children's Hospital Affiliated to Medical College of Zhejiang University, Hangzhou

All Listed Sponsors
lead

Jiangxi Qingfeng Pharmaceutical Co. Ltd.

INDUSTRY

NCT04737837 - A Real World Study on the Efficacy and Safety of Lacosamide as Add-on Therapy for Focal-onset Epilepsy | Biotech Hunter | Biotech Hunter